ArticleAnnals of surgical oncology2024

Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis.

Francesco Abboretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.